Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora In Vitro

Xinyao Liu; Zhi Zhang; Jitong Sun; Renjie Fang; Xin Ran; Yuzhou Liu; Yuping Ran

doi:10.1080/21501203.2024.2383640

Mycology (Aug 2024)

Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora In Vitro

Xinyao Liu,
Zhi Zhang,
Jitong Sun,
Renjie Fang,
Xin Ran,
Yuzhou Liu,
Yuping Ran

Affiliations

Xinyao Liu: Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Zhi Zhang: Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Jitong Sun: Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Renjie Fang: ShenYunZhiHe Company, Qidian BLDG, Beijing, China
Xin Ran: Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Yuzhou Liu: ShenYunZhiHe Company, Qidian BLDG, Beijing, China
Yuping Ran: Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China

DOI: https://doi.org/10.1080/21501203.2024.2383640

Abstract

Read online

Fonsecaea monophora is one of the common pathogenic species of Chromoblastomycosis (CBM). Antimicrobial photodynamic therapy (aPDT) shows promise as a new treatment for CBM. In this study, we evaluated the effectiveness of COP1T-HA which is a porous organic cage and aPDT against Fonsecaea spp. in vitro.

Published in Mycology

ISSN: 2150-1203 (Print); 2150-1211 (Online)
Publisher: Taylor & Francis Group
Country of publisher: United Kingdom
LCC subjects: Science: Biology (General); Science: Microbiology
Website: https://www.tandfonline.com/journals/tmyc

About the journal

Abstract

Keywords